-
公开(公告)号:US20180140578A1
公开(公告)日:2018-05-24
申请号:US15821111
申请日:2017-11-22
发明人: Deepak Nijhawan , Ting Han , Nicholas H. Gaskill
IPC分类号: A61K31/404 , A61K31/381 , A61K31/498 , A61P35/00 , G01N33/574
CPC分类号: A61K31/404 , A61K31/381 , A61K31/498 , A61P35/00 , C12Q1/6886 , G01N33/57484
摘要: In one aspect, provided herein are methods for treating cancer in a subject, comprising: (1) identifying in the subject the presence of a mutation in a splicing factor selected from the group consisting of U2AF1, SF3B1, SRSF2, and ZRSR2; and/or determining in the subject an increased amount of DCAF15 compared to a control, and (2) inhibiting an activity of RBM39 in the subject. In some embodiments, the inhibiting step can include promoting RBM39 degradation, preferably in a DCAF15-dependent manner. Compositions are also provided.